A multi-stakeholder platform hosted by the University of Basel is addressing health challenges in Africa through entrepreneurial innovation with a focus on supporting local ecosystems and implementation.
Supported by the Swiss State Secretariat for Education, Research and Innovation (SERI) and in collaboration with Novartis and the Swiss TPH, MIRAHI (Making Innovation a Reality – African Health Initiative) – a play on the Japanese word mirai (future) – aims to address the most pressing African health issues.
Starting from key challenges, co-defined by African and Swiss stakeholders, MIRAHI engages and supports the African innovation and entrepreneurship ecosystem to search for and support promising innovations. These innovations have the potential to positively impact health outcomes in local communities.
Together with Challenge Owners, including governments, international organisations and local and international actors in private sector and civil society, promising solutions will be selected, validated, and implemented in a coordinated fashion.
The first challenge – the distribution of COVID-19 vaccines in Sub-Saharan Africa – will be launched in January. Entrepreneurs and civil society innovators will be invited to submit their solution and how it can be applied to the distribution of vaccines.
Currently, MIRAHI is finalising its core partnerships and is looking forward to hearing from interested stakeholders at Pascal.Froehlicher@unibas.ch.
MIRAHI is an initiative of the STELLA Centre of Excellence (Strengthening Translational Ecosystems for Lifesaving Local Access) at the University of Basel (Contact: email@example.com).